Skip to content

Mark Rowand, MD

NPI 1104948702ActiveIndividual· Family Medicine, Sports Medicine· Dallastown, PA

Family Medicine, Sports Medicine (MD) in Dallastown, Pennsylvania, trained at Pennsylvania State University College of Medicine (class of 2006). Their prescriptions cost Medicare Part D more than their services did: $1,402,142 for 12,188 claims, against $315,011 paid for services in 2024. Pfizer Inc. was the largest of 15 companies reporting payments in 2025, $913.87 in all, mostly food and beverage.

Overview

NPI1104948702
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedApr 4, 2007
Last updated in NPPESApr 11, 2016

Specialties and licenses

TaxonomyCodeLicenseState
Family Medicine, Sports Medicine Primary207QS0010XMD4386558PA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Family Practice (PA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients459
Services billed14,485 across 107 procedure codes
Paid by Medicare$315,011

Part D prescriptions in 2024

Prescriptions (claims)12,188 · 26,950 30-day fills
Patients859
Total drug cost$1,402,142
Generic share87% of claims

Medicare sources and data years

Education and affiliations

Medical schoolPennsylvania State University College of Medicine
Graduation year2006
Medicare specialtyFamily Practice
Secondary specialtiesSports Medicine
TelehealthOffers telehealth

Medical groups

Hospital affiliations

Other facilities

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$913.87 · 53 payments from 15 companies
  • 2024$1,083 · 56 payments from 18 companies

Top paying companies in 2025

CompanyAmountPayments
Pfizer Inc.$302.8720
Abbvie Inc.$196.4712
Glaxosmithkline, LLC.$69.163
Astrazeneca Pharmaceuticals LP$64.174
Novo Nordisk Inc$47.382

What the 2025 payments were for

  • Food and Beverage$913.87 · 53 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records